MedPath

Efficacy of Three Antiemetics in Preventing Nausea and Vomiting

Phase 4
Completed
Conditions
Nausea and Vomiting
Interventions
Registration Number
NCT05533281
Lead Sponsor
The Second Affiliated Hospital of Chongqing Medical University
Brief Summary

To explore the effect of commonly used antiemetic drugs on reducing nausea and vomiting caused by intravenous tramadol injection, so as to reduce the incidence of nausea and vomiting in clinical use of tramadol and provide guidance for the clinical use of tramadol injection

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • American Society of Anesthesiologists classification I-II
  • 18.5≤BMI≤28
  • Patients who receiving breast and thyroid surgery and requiring general anesthesia and receive PCIA
  • Voluntarily and be able to understand and sign the informed consent form
Exclusion Criteria
  • Long-term use of analgesics, psychotropic drugs (including opioids, NSAIDS, antidepressants) history
  • History of allergy to opioids
  • Patients with a history or family history of epilepsy that has not been controlled by treatment
  • Sedatives and antidepressants were used 24 hours before surgery
  • Failure to cooperate with the study for any reason or in the opinion of the investigator

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
normal salinenormal salineEqual dose of normal saline was given 30 minutes in advance, and then tramadol 1.5mg/kg was given intravenously to ensure constant speed.
metoclopramidemetoclopramideMetoclopramide was given 30 minutes in advance, and then tramadol 1.5mg/kg was injected intravenously with a micropump at a constant speed.
tropisetrontropisetronTroisetron was given 30 minutes in advance, and then tramadol 1.5mg/kg was intravenously injected with a micropump at a constant speed.
dexamethasonedexamethasoneDexamethasone was given 30 minutes in advance, and then tramadol 1.5mg/kg was injected intravenously with a micropump at a constant speed.
Primary Outcome Measures
NameTimeMethod
NRS score of nausea and vomitingFrom before administration to 10min after administration

NRS score of nausea and vomiting was assessed by numerical rating scale (0-10, 0 representing no nausea and 10 the worst nausea imaginable)

Secondary Outcome Measures
NameTimeMethod
Incidence of extra treatment for postoperative nausea and vomitingFrom end of operation to 24 hours after operation

Incidence of extra treatment for postoperative nausea and vomiting was assessed by whether patient using other treatment for postoperative nausea and vomiting during the the follow-up visits after surgery

Incidence of postoperative nausea and vomitingFrom end of operation to 24 hours after operation

PONV is recorded according to whether the patient present nausea and vomiting during the follow-up visits after surgery

NRS score of postoperative nausea and vomitingFrom end of operation to 24 hours after operation

NRS score of nausea and vomiting was assessed by numerical rating scale (0-10, 0 representing no nausea and 10 the worst nausea imaginable)

Trial Locations

Locations (1)

The Second Affiliated Hospital, Chongqing Medical University

🇨🇳

Chongqing, Chongqing, China

© Copyright 2025. All Rights Reserved by MedPath